Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Dermatologists should monitor potassium levels in women taking spironolactone for acne, hair loss, and hirsutism.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Doctors are prescribing spironolactone more often to treat acne and skin conditions in teenagers, and it seems safe and well-tolerated.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Baricitinib is effective and safe for treating severe alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Ivarmacitinib may effectively treat complex atopic dermatitis and related hair loss.

Statins do not help improve alopecia areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Stabilizing HIF-1A in hair follicles may reduce oxidative stress and promote hair growth by increasing glycolysis.

Er:YAG laser therapy effectively treats Hailey-Hailey disease, leading to long-term remission and improved quality of life.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.